AKANDA CORP.
corporate_fare Company Profile
AKANDA CORP. (NASDAQ:AKAN) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 25 items for AKAN at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-09, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for AKAN spans 6-K, 20-F, F-1/A, F-1.
Recent high-impact activity:
- Akanda Appoints Christopher Cooper as New CEO; Interim CEO Katie Field Resigns
- Akanda's FTF Collects First Cash Lease Payment on 200 KM Fiber Network, Eyes Expansion
- Nasdaq Extends Akanda's Deadline to December 13 for Equity Compliance
- AKANDA CORP. Receives Nasdaq Delisting Notice for Negative Stockholders' Equity
- Akanda Corp. Regains Nasdaq Compliance, Resolving Delisting Risk
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for AKAN, detected from its recent SEC filings · based on capital-structure filings through 2026-04-02.
Special Shareholder Meeting Called · Deletion of Class A Special Shares
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →
Insider Transactions
AKAN files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.